Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:511-516
doi: 10.1161/hq0302.105359
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brinkman, H.-J. M.
Right arrow Articles by van Mourik, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brinkman, H.-J. M.
Right arrow Articles by van Mourik, J. A.
Related Collections
Right arrow Apoptosis
Right arrow Coagulation
Right arrow Other Research
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:511.)
© 2002 American Heart Association, Inc.


Thrombosis

Phospholipid-Binding Domain of Factor VIII Is Involved in Endothelial Cell–Mediated Activation of Factor X by Factor IXa

Herm-Jan M. Brinkman; Koen Mertens; Jan A. van Mourik

From the Department of Plasma Proteins and Blood Coagulation (H.-J.M.B., K.M., J.A.v.M.), CLB, Sanquin Blood Supply Foundation, and the Department of Vascular Medicine (J.A.v.M.), Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands, and Utrecht Institute of Pharmaceutical Sciences (K.M.), Utrecht University, Utrecht, the Netherlands.

Correspondence to J.A. van Mourik, Department of Blood Coagulation, CLB, Plesmanlaan 125, 1066 CX Amsterdam, Netherlands. E-mail J_van_Mourik{at}clb.nl

Apparently quiescent, nonapoptotic endothelial cells mediate the activation of factor X by activated factor IX in the presence of its cofactor, activated factor VIII. In a previous study, we reported that during the activation of factor X, the interaction of the cofactor with the endothelial cell membrane clearly differs from the interaction of the cofactor with artificial lipid membranes. In the present study, we identified the peptide domain of factor VIII involved in the assembly of the enzyme-cofactor complex on the endothelial cell surface. With the use of monoclonal antibodies against different peptide sequences on the factor VIII light chain, it was observed that the lipid-binding region of the C2 domain on the factor VIII light chain mediates the assembly of the factor X–activating complex on the endothelial cell surface. In addition, a synthetic peptide that constitutes region Ala2318-Tyr2332 of the C2 domain and that is known for its ability to inhibit the binding of factor VIII to artificial lipid membranes also showed inhibition of the cofactor activity of factor VIII on endothelial cells. Thus, the carboxy-terminal part of the factor VIII light chain not only contains sites involved in lipid binding but also contains sites involved in complex assembly on the endothelial cell membrane.


Key Words: endothelial cells • factor X activation • factor VIII




This article has been cited by other articles:


Home page
BloodHome page
H. Meems, A. B. Meijer, D. B. Cullinan, K. Mertens, and G. E. Gilbert
Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity
Blood, October 29, 2009; 114(18): 3938 - 3946.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T.-C. Hsu, K. P. Pratt, and A. R. Thompson
The factor VIII C1 domain contributes to platelet binding
Blood, January 1, 2008; 111(1): 200 - 208.
[Abstract] [Full Text] [PDF]